We have previously shown that unsaturated fatty acids amplify platelet-derived-growth-factor (PDGF)-induced protein kinase C (PKC) activation in vascular smooth-muscle cells (VSMCs). Diacylglycerol-induced PKC activation is normally terminated by diacylglycerol kinases (DGKs). We thus hypothesized that fatty acids act by inhibiting a DGK. Fractionation of VSMC extracts demonstrated that the DGK α isoform was the major DGK activity present. PDGF markedly increased the DGK activity of cultured cells. An inhibitor selective for the DGK α isoform, R59949 [3-o2-[4-(bis-(4-fluorophenyl)methylene]-piperidin-1-yl)ethylq-2,3-dihydro-2-thioxo-4(1H)-quinazolinone], abolished the growth-factor-induced increase in DGK activity, but had little effect on basal activity. PDGF thus selectively activates DGKα. Epidermal growth factor and α-thrombin
INTRODUCTION
Diacylglycerol kinases (DGKs) phosphorylate sn-1,2-diacylglycerol (DAG) released during stimulus-induced phosphoinositide turnover [1] [2] [3] . As such, DGKs attenuate DAG-mediated protein kinase C (PKC) activation. Cells express multiple DGK isoforms. Sequence comparisons reveal a conserved DGK catalytic domain, but varied regulatory motifs, suggesting divergent mechanisms of regulation [1] [2] [3] . Several groups have reported stimulation of DGK activities by a variety of signals [4] [5] [6] [7] [8] [9] [10] [11] . Most of these studies did not identify the specific DGKs involved. Further complicating DGK regulation are observations that only some DAG pools are targeted by DGKs [11] [12] [13] . During cell stimulation, DGKs appear to selectively phosphorylate an arachidonate-enriched DAG pool deriving from phosphoinositide (PI) turnover [11] [12] [13] . DGKs thus initiate PI resynthesis in addition to attenuating PKC activation.
In diabetes, chronic PKC activation has been linked to vascular changes leading to multiple complications [14, 15] . Pharmacological PKC activation with phorbol esters mimics diabetes-induced effects on the vasculature, including increased trans-endothelial permeability [16] , enhanced synthesis of extracellular-matrix proteins [17] and inhibition of cytosolic Ca# + signalling [18, 19] . Conversely, PKC inhibition can attenuate some of these same events [20] . Such findings strongly implicate PKC in the complications of diabetes. The origin of diabetesAbbreviations used : DAG, sn-1,2-diacylglycerol ; DGK, diacylglycerol kinase ; diC 10 , sn-1,2-didecanoylglycerol ; EGF, epidermal growth factor ; NEFA, non-esterified (' free ') fatty acid ; FGFb, fibroblast growth factor-2 ; MEM, (Earle's) minimal essential medium ; PA, phosphatidic acid ; PDGF, plateletderived growth factor ; PI, phosphoinositide ; PKC, protein kinase C ; R59949, 3-o2-[4-(bis-(4-fluorophenyl)methylene]piperidin-1-yl)ethylq-2,3-dihydro-2-thioxo-4(1H)-quinazolinone ; VSMC, vascular smooth-muscle cell. 1 Deceased. 2 To whom correspondence should be addressed (e-mail jpwalsh!iupui.edu).
stimulated total DGK activity similarly to PDGF. Activation by epidermal growth factor was sensitive to R59949, again suggesting involvement of DGKα. However, the α-thrombin-induced activity was unaffected by this agent. Unsaturated fatty acids inhibited growth-factor-induced DGKα activation, but had no effect on basal activity. Fatty acids also amplified the PDGF-induced increase in cell diacylglycerol content. These results indicate that inhibition of DGKα contributes to fatty-acid-induced amplification of PKC activation. Increased levels of fatty acids in diabetes may thus contribute to chronic PKC activation associated with this disorder.
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induced DAG and its role in PKC activation is less clear. Diabetes increases the flux of label from glucose into DAG, indicating that de no o synthesis contributes to increased DAG concentrations [14, 21] . Circulating non-esterified (' free ') fatty acids (NEFA) are increased in people with diabetes [22] . We initially hypothesized that NEFA activate PKC in the diabetic vasculature by increasing de no o DAG synthesis. However, induction of de no o DAG synthesis by exposing vascular smooth muscle cells (VSMCs) to fatty acids did not correlate with PKC activation [23] . This suggested that de no o DAG synthesis and PKC activation are independent events. Growth factors activate DAG-dependent PKCs by increasing PI turnover to DAG [24] . Diabetes impairs flux through the PI cycle [25] . Increased PI hydrolysis is thus unlikely to contribute to DAG accumulation or PKC activation in diabetes. Inhibition of a DGK could activate PKC. Given the role of DGKs in PI resynthesis, DGK inhibition could also contribute to decreased PI turnover. In fact, Nobe et al. have reported markedly reduced DGK activities in aortas and kidneys from diabetic rats [26] . Several other tissues did not exhibit this change. Inhibition of a DGK may thus contribute to diabetes-related PKC activation. We now demonstrate that DGKα is the major DGK isoform in carotid smooth muscle and cultured VSMCs. We also demonstrate that DGKα activity is selectively stimulated by plateletderived growth factor (PDGF) and epidermal growth factor (EGF). α-Thrombin also stimulated DGK activity in these cells, but this appeared to reflect activation of another DGK isoform. Unsaturated NEFA inhibited growth factor-induced increases in DGKα activity. This effect correlated with their ability to amplify PDGF-induced PKC activation, which we have previously reported [23] . These results indicate that inhibition of DGKα activation contributes to the amplification of PKC activation by unsaturated NEFA and that inhibition of DGKα activation may contribute to PKC activation in diabetes. ) were prepared by digestion of the corresponding phosphatidylcholines with Bacillus cereus phospholipase C [28] . Fatty acids and PMA were from Sigma. Escherichia coli strain WH1061, harbouring the inducible plasmid pSD005 that encodes a synthetic E. coli DGK with an Nterminal histidine tag, was a gift of Dr James Bowie, University of California at Los Angeles, Los Angeles, U.S.A. [29] .
EXPERIMENTAL

Materials
Cell culture
Primary cultures of VSMCs were prepared from porcine carotid arteries as described previously [23] . For experiments, 5i10% cells\ml from passages 3-7 were seeded into 35-mm-or 100-mm-diameter dishes in 1.5 or 12 ml of (Earle's) minimal essential medium (MEM) supplemented with 10 % (v\v) fetalcalf serum, 100 units\ml penicillin and 100 µg\ml streptomycin. The culture medium was replaced every 48 h. Cells reached near confluence after 7 days. They were rendered quiescent by washing once with antibiotic-free, low-phosphate MEM, which was prepared by supplementing phosphate-free MEM (Gibco BRL, Grand Island, NY, U.S.A.) with 50 µM NaH # PO % , 0.1 % fetalcalf serum and 20 mM Hepes, pH 7.4. The cells were then incubated in the same medium for 24 h. Stock solutions of fatty acids and albumin were prepared as described previously [23] and added directly to culture media to give the desired final concentrations. The final albumin concentration in all experiments was 50 µM (0.33 %).
In situ assay of DGK activity DGK activity was assayed in intact cells by monitoring the phosphorylation of exogenously added diC "! , a short-chain DAG analogue [30] . Quiescent cells in 35-mm-diameter dishes were labelled by adding 50 µCi\dish of [$#P]P i to the culture medium. After 10 min, diC "! was added to a final concentration of 50 µM (10 µl of 7.5 mM diC "! in ethanol). After an additional 10 min, the cells were stimulated with 10 ng\ml PDGF (10 µl of 1.5 µg\ml in MEM). Stimulation with other growth factors was performed in an identical fashion. Final concentrations used were : EGF, 40 ng\ml ; α-thrombin, 20 NIH (National Institutes of Health) units\ml ; FGFb, 25 ng\ml ; angiotensin II, 100 nM ; carbachol, 100 µM ; and phenylephrine, 100 µM. After 20 min incubation with PDGF, the medium was aspirated and cells were rinsed once with ice-cold 10 mM Tris\HCl\0.85 % NaCl. The cells were harvested by scraping them into 0.75 ml of 0.1 M HCl and transferring them to a glass test tube. Lipids were then extracted by adding 2.8 ml of methanol\chloroform (2 : 1, v\v). After 30 min on ice, 0.95 ml of CHCl $ and 0.95 ml of 0.1 M HCl were added and the phases separated by centrifugation. To perform thin layer chromatography (TLC), a fixed volume of the lower phase was carefully removed and evaporated under a stream of N # . The residue was dissolved in 20 µl of CHCl $ and 10 µl of that solution spotted onto silica gel 60 plates (E. Merck, Darmstadt, Germany). The plates were developed in ethyl acetate\iso-octane\acetic acid\water (45 : 20 : 12 : 6, by vol.), which separates didecanoyl phosphatidic acid (didecanoyl PA) from endogenous, long-chain PA [30] . Spots corresponding to didecanoyl [$#P]PA were detected by autoradiography, scraped off and counted for radioactivity in a liquid-scintillation analyser. To normalize activities, parallel experiments were performed using unstimulated control cells, the activity of which was taken to be 100 % (basal DGK activity). The extent of DGKα stimulation by PDGF, expressed as a percentage of the basal DGK activity, did not vary by more than 10 % when multiple determinations were performed with a single set of VSMC plates. It ranged from 80 to 150 % with different VSMC preparations, with higher stimulation generally observed in earlier passages. As described in the Results section below, the increase in DGK activity with PDGF stimulation reflects activation of DGKα, while the basal diC "! phosphorylation is due to the activity of other DGK isoforms.
DAG and diC 10 mass assays
Recombinant, histidine-tagged E. coli DGK for use in these assays was prepared from E. coli strain WH1061\pSD005 by Ni(II)-chelate chromatography [31] . Endogenous long-chain DAG in VSMC extracts was assayed as described previously [23] . To assay diC "! , cells in 60-mm-diameter plates were chilled on ice and the medium aspirated. Cell monolayers were washed twice with 5 ml of ice cold Dulbecco's PBS without Ca# + or Mg# + . They were then harvested by scraping and the lipids extracted into neutral methanol\chloroform as described by Preiss et al. [32] . DiC "! in these extracts was determined using a radioenzymic assay with E. coli DGK [32] . Short-chain DAG analogues are phosphorylated by E. coli DAG kinase similarly to naturally occurring DAG [33] . To separate didecanoyl PA from the PA derived from endogenous long-chain DAG present in these cells, the radiochemical products were separated by TLC on silica-gel-60 plates, which were developed with ethyl acetate\ iso-octane (2,2,4-trimethylpentane)\acetic acid\water (45 : 20 : 12 : 6, by vol.) as described above. Spots corresponding to didecanoyl [$#P]PA were detected by autoradiography, scraped off and counted in a liquid-scintillation analyser. A solution of diC "! calibrated using a standard ester assay [34] was used to prepare a standard curve.
In vitro DGK activity assays
In itro DGK activity assays utilized Triton X-100\hexadecyl-sulphobetaine mixed micelles to disperse and deliver the DAG substrate [35] . This system also permitted dispersal of R59949 for studies of in itro inhibition [35] . To examine for arachidonoyl DAG-selective DGK (DGKε), activities were determined separately with sn-1-palmitoyl-2-oleoylglycerol and sn-1-stearoyl-2-arachidonoylglycerol [36, 37] . Ca# + activation of VSMC DGKs was determined in an octyl glucoside\phosphatidylserine assay as described previously [35] .
Antibody preparation and immunoblotting
To prepare polyclonal anti-DGKα antibodies, residues 2-336 of porcine DGKα, which encompass the entire regulatory region, were expressed as a glutathione S-transferase fusion in E. coli [38] . Immunization of rabbits with the recombinant protein and collection of antisera were performed by Alpha Diagnostic International, San Antonio, TX, U.S.A. Two rabbits each received five 150 µg injections of antigen at 2-week intervals. The first injection was in 0.5 ml of complete Freund's adjuvant and the others in 0.5 ml of incomplete adjuvant. Antisera were collected at weeks 7, 9, 11 and 13. Specific reactivity toward DGKα, purified from porcine thymus [35] , was confirmed by immunoblotting. To prepare immunoblots, samples were electrophoresed on SDS\7.5 %-PAGE gels and transferred to nitrocellulose. Bound antibodies were detected using an enhanced chemiluminescence kit (ECL2 ; Amersham, Arlington Heights, IL, U.S.A.) and horseradish-peroxidase-conjugated goat antirabbit antibodies (Santa Cruz Biotechnology, Santa Cruz, CA, U.S.A.). Immunoprecipitation of DGKα was performed by adding 0.2 % Triton X-100 to 100 µl of the pooled MonoQ peak fractions (see below). The samples were pre-cleared with 20 µl of Protein A\G-agarose (Santa Cruz) for 30 min and then incubated with 3 µl of anti-DGKα antibody. After 30 min, 30 µl of Protein A\G-agarose was added and the incubation continued another 2 h. The immunocomplexes were pelleted and the supernatant saved for DGK assay. The Protein A\G-agarose immunocomplexes were washed twice with buffer containing 0.2 % Triton X-100, eluted, and examined by immunoblotting. Control immunoprecipitations were performed with 3 µl of pre-bleed antisera instead of anti-DGKα.
Chromatographic resolution of DGK activities from carotid smooth muscle
All purification steps were carried out at 4 mC. Porcine carotid arteries were harvested and the adventitia removed. They were cut open lengthwise and the endothelial layer scraped off. The media were minced into small pieces with razor blades. These were homogenized in a blender and a Polytron homogenizer with 3 vol. of 20 mM Tris\HCl (pH 7.4)\0.25 M sucrose\2.5 mM EGTA\1 mM MgCl # \1 mM PMSF\1 mM dithiothreitol\ 0.05 mM ATP\10 µg\ml aprotinin\10 µg\ml leupeptin. This homogenate was centrifuged at 1000 g for 10 min to pellet nuclei and unbroken cells. The postnuclear supernatant was further fractionated into cytosol and membranes by centrifugation at 100 000 g for 60 min. The cysosolic supernatant was diluted to a protein concentration of 5 mg\ml in the same buffer with the NaCl concentration adjusted to 100 mM and addition of Triton X-100 to 0.02 %. The membranes were suspended at a protein concentration of 5 mg\ml in the same buffer with 100 mM NaCl and 1 % Triton X-100. The membranes and cytosol (2 mg of protein) were fractionated over a Mono Q HR 5\5 column (Amersham Pharmacia Biotech, Piscataway, NJ, U.S.A.). The column was eluted with a 30 ml gradient of 100-500 mM NaCl in the same buffer. The Triton concentration in the eluting buffer was 0.02 % in all cases. The flow rate was 0.2 ml\min and 0.5 ml fractions were collected. The conductivity of the column effluent was monitored. Peak fractions were pooled and stored at k70 mC.
Sulphopropyl (SP)-Sepharose chromatography of DGK activities recovered from Mono Q was performed as previously described [35] .
RESULTS
DGK α is the major DGK activity in vascular smooth muscle
Individual cells may express multiple DGK isoforms [1] [2] [3] . To characterize the DGK activities in vascular smooth muscle, cytosol and membrane fractions were prepared from medial layers of porcine carotid arteries and fractionated over Mono Q. Cytosol contained 85 % of the total DGK activity and the membranes 15 %. The major cytosol activity was eluted at 100 mM NaCl, and the peak fractions were immunoreactive with anti-DGKα antibodies ( Figure 1A) . A second cytosolic DGK activity, which did not react with the DGKα antibodies, was eluted at 250 mM NaCl. The membrane fractions also contained two peaks of DGK activity ( Figure 1B) . The first, which was eluted at 100 mM NaCl, again corresponded to DGKα. Partitioning of DGKα between membranes and cytosol has been previously noted [39, 40] . The membrane activity that was eluted at 190 mM NaCl was selective for sn-2-arachidonoyl DAG, indicating that it is DGKε [36, 37] . These observations are consistent with a previous report that multiple animal tissues express three chromatographically resolvable DGKs, one of which is a membrane-bound, arachidonate-selective isoform [41] . Both the cytosolic and membrane-bound forms of DGKα were
Figure 1 Chromatographic separation of VSMC DGK activities
Cytosol and membrane fractions of porcine carotid media were prepared and the DGK activities resolved over Mono Q as described in the Experimental section. The first peak of activity eluted from Mono Q was also rechromatographed over SP-Sepharose. Active fractions were examined for DGKα immunoreactivity. Western blots of individual column fractions with anti-DGKα antibodies are shown above the activity profiles. The M r of the immunoreactive band in membrane fractions 23 and 24 does not correspond to DGKα, indicating that it is non-specific. Figure 1 were pooled and examined for arachidonate selectivity, stimulation by 20 µM Ca 2 + and inhibition by 2 mol % R59949 as described previously [35] . Numbers of the column fractions pooled for assays are also indicated. stimulated by Ca# + and inhibited by R59949, but these agents did not affect the other DGK activities ( Table 1) . We have previously shown R59949 to be selective for Ca# + -dependent DGK isoforms, including DGKα [35] . The in itro inhibition observed with the VSMC DGKs is in excellent agreement with our previous demonstration of 68 % inhibition of porcine DGKα, but only minimal inhibition of several Ca# + -independent DGKs from a variety of animal tissues [35] . Membranes and cytosol from cultured VSMCs were also immunoreactive with anti-DGKα antibodies (results not shown).
To confirm that the activity eluted at 100 mM NaCl consisted largely of DGKα, the pooled peak fractions were immunoprecipitated with anti-DGKα antibody. About 85 % of the activity was precipitated. Moreover, the activity remaining in the supernatant was inhibited by R59949 and activated by Ca# + , similarly to the total peak activity. The activity eluted from Mono Q at 100 mM NaCl was also fractionated over SPSepharose. Only a single peak of DGK activity, which was coeluted with DGKα immunoreactivity at 190 mM NaCl, was observed ( Figure 1C ). This is consistent with our previous observation that DGKα from porcine thymus is eluted from SPSepharose at 200 mM NaCl [35] . These results indicate that the peak of DGK activity eluted at 100 mM NaCl consists largely or entirely of DGKα, and that this isoform represents the major DGK activity in vascular smooth muscle.
DGKα is selectively activated by PDGF in cultured VSMCs
A variety of stimuli increase DGK activities in cultured cells [4] [5] [6] [7] [8] [9] [10] . PDGF stimulates a DGK activity in VSMCs [42] . We examined the effect of PDGF on VSMC DGK activity using an in situ assay based on phosphorylation of exogenously supplied diC "! , a short-chain DAG analogue. This method has been employed by several groups to measure DGK activities in living cells [12, 30, [43] [44] [45] . DiC "! behaves similarly to naturally occurring DAG in in itro assays, and its in i o phosphorylation provides a measure of DGK activity that does not include PA arising from endogenous DAG [30] . As shown in Figure 2 , PDGF induced a rapid increase in diC "! phosphorylation, indicating that is stimulating DGK activity in these cells. Note that this assay measures only phosphorylation of diC "! , the long-chain PA arising from phosphorylation of endogenous DAG being removed by the TLC step. As short-chain fatty acids are not normal constituents of cell phospholipids, PA arising from pathways other than DAG phosphorylation is also excluded. These results thus indicate that PDGF is directly stimulating DGK activity. If the diC "! concentration added to the medium was reduced to 10 or 25 µM, the diC "! [$#P]PA produced in
Figure 2 Stimulation of VSMC in situ DGK activity by PDGF
The increase in activity in response to PDGF was abolished by the DGKα-selective inhibitor R59949. This agent had no effect on basal DGK activity. P values are as follows : control versus PDGF only, n l 14, P 10 − 9 ; PDGFjR59949 versus R59949 only, n l 6, not significant ; control versus R59949 only, not significant.
response to PDGF was 68p10 % and 103p6 % of that observed with 50 µM diC "! . Total diC "! associated with the cells increased linearly with added diC "! (results not shown). These results indicate that the concentration of diC "! used for these experiments is saturating the PDGF-stimulated DGK activity, and that changes in endogenous DAG are unlikely to significantly alter diC "! phosphorylation. As shown above, among the DGK activities in VSMCs, DGKα is selectively inhibited by R59949. Although R59949 and the related compound, R59022, only partially inhibit DGK activities in itro, in i o studies have noted nearly complete inhibition of sensitive DGK activities by these agents [4, 7, 42, 45] . R59949 abolished the PDGF-induced increase in diC "! phosphorylation, but had only a small effect on basal DGK activity (Figure 2) . These results indicate that PDGF selectively activates DGKα, and that other DGKs account for the basal activity in unstimulated VSMCs.
We also examined whether other stimuli can activate DGK in these cells. Stimulation of diC "! phosphorylation by EGF was
Figure 3 Stimulation of VSMC in situ DGK activity by α-thrombin
The increase in activity in response to 20 NIH units/ml of α-thrombin was unaffected by R59949. P values are as follows : control versus thrombin only, P 0.001 ; control versus thrombinjR59949, P 0.001 ; R59949 only versus thrombin only, P 0.0005 ; R59949 only versus thrombinjR59949, P 0.0005 ; control versus R59949 only, not significant ; thrombin versus thrombinjR59949, not significant ; n l 6 for all experiments. Fatty acids inhibit diacylglycerol kinase α activation similar to that with PDGF. FGFb also stimulated DGK activity, but only about 25 % over basal. For both of these growth factors, the increase in diC "! phosphorylation was completely inhibited by R59949, suggesting that they are also activating DGKα. α-Thrombin stimulated diC "! phosphorylation similarly to PDGF (Figure 3 ). This stimulation was unaffected by R59949, suggesting that α-thrombin is activating a different DGK. These
Figure 5 Effects of fatty acids on growth-factor-induced DGKα activation in VSMCs
Cells were pretreated for 4 h with 150 µM NEFA bound to 50 µM albumin and then stimulated with 10 ng/ml PDGF or 40 ng/ml EGF for 20 min. DGK activity was determined using the in situ assay as described in the Experimental section. Results in each panel are meanspS.E.M. for multiple independent determinations with and without growth factor or fatty acid treatment as indicated. P values for growth-factor-treated cells versus fatty-acid-plus-growth-factor-treated cells are as follows : (A), PDGF, oleate, n l 11, P 0.0001 ; (B), PDGF, palmitate, n l 9, not significant ; (C), PDGF, elaidate, n l 6, P 0.002 ; (D) EGF, oleate, n l 4, P 2i10 − 7 .
results also confirm the strong in i o selectivity of R59949 among DGK isoforms [35] . No effect on diC "! phosphorylation was observed with angiotensin II, carbachol or phenylephrine (results not shown).
PKC can phosphorylate DGKs [46] [47] [48] . Moreover, phorbol esters have been reported to stimulate cytosol-to-membrane translocation of DGK activities [8, 9] . It is thus possible that one or more PKC isoforms mediate PDGF-induced DGKα activation. It is also possible that diC "! used for the in situ DGK assay activates a PKC, which in turn activates one of the DGKs that contribute to the basal activity we observed. To test these possibilities, we examined PDGF stimulation of DGK activity in VSMCs depleted of DAG-dependent PKCs by PMA pretreatment. Cultured porcine VSMCs express the DAG-dependent α and ε PKC isoforms, as well as the DAG-independent PKCζ [23] . Phorbol-ester treatment depleted PKCα and PKCε (Figure 3) . PKC depletion had only small effects on basal and PDGF-stimulated DGK activities (Figure 4 ). This indicates that PDGF-induced activation of DGKα does not require a DAG-dependent PKC and that the basal, unstimulated activity observed in these cells does not reflect activation of the other DGKs via diC "! -induced activation of PKCα or PKCε. Direct PKC stimulation by short-term PMA treatment (0-20 min) was also without effect on diC "! phosphorylation (results not shown). Other groups have also reported that DGKs can be activated independently of PKC [11, 12, 49] . These findings indicate that PDGF-dependent DGKα activation is not mediated by classical (α) or novel (ε) PKCs.
Figure 6 Effects of NEFA on membrane/cytosol distribution of DGKα
Quiescent VSMCs were exposed to fatty acids for 4 h. Membrane and cytosol fractions were then prepared as described previously [23] and examined for DGKα by immunoblotting. 
Fatty acids inhibit growth-factor-induced DGKα activation
We have previously shown that oleate amplifies PDGF-induced activation of PKCα and PKCζ [23] . Palmitate did not have this effect. Addition of NEFA to in itro assays can stimulate DGK activities [50, 51] . Treatment with oleate or palmitate for 4 h had little effect on basal diC "! phosphorylation ( Figures 5A and 5B ). However, oleate inhibited the PDGF-induced increase in DGK activity by 60 % (Figure 5A ). Palmitate, by contrast, had only a small effect ( Figure 5B ). Inhibition of DGKα activation by oleate, but not palmitate, is consistent with our previous finding that that oleate, but not palmitate, amplifies PDGF-induced PKC activation in VSMCs [23] . Elaidate, the trans-unsaturated analogue of oleate, also inhibited DGK activation ( Figure 5C ). Elaidate amplified PDGF-induced PKCα and PKCζ activation similarly to oleate (results not shown). Oleate also inhibited the stimulation of DGK activity by EGF ( Figure 5D ). The extent of inhibition was similar to, or slightly greater than, that seen with PDGF-stimulated DGK activity. Oleate caused only modest (30 %) inhibition of the increase in DGK activity stimulated by α-thrombin (results not shown). Fatty acids had no effect on the cell content of DGKα, as estimated by immunoblots (Figure 6 ). Varying the time of oleate exposure from 10 min to 24 h also had no effect on DGK levels (results not shown). Fatty acids did not alter the concentration of diC "! associated with the cells (Table  2 ), indicating that the effects on in situ DGK activity do not reflect diversion of diC "! into other pathways. These results are consistent with the hypothesis that unsaturated NEFA amplify PDGF-induced PKC activation by impairing the activation of DGKα.
Figure 7 Effect of oleic acid on the PDGF-induced increase in DAG
Quiescent VSMCs were treated with oleic acid for 4 h and then stimulated with PDGF. DAG masses were determined at various times after PDGF addition. Data are meanspS.E.M. for four independent experiments. Symbols used : #, cells treated with 150 µM oleic acid and 50 µM albumin ; $, control cells treated with 50 µM albumin only. P values were significant at 5 min (P 0.05) and 10 min (P 0.02).
Fatty acids amplify PDGF-induced DAG accumulation
PDGF activates a PI-dependent phospholipase C that cleaves PIs to produce DAG [24] . If inhibition of DGKα contributes to the NEFA-induced amplification of PKC activation, then there might be an increase in the DAG peak occurring after PDGF stimulation. As shown in Figure 7 , oleate pretreatment, which we have previously shown to have no effect on basal DAG, doubled the increase in DAG after PDGF stimulation. This is consistent with our previous observation that oleate has no effect on basal PKC activity, but amplifies PKC activation in response to PDGF stimulation [23] .
DISCUSSION
We have demonstrated that PDGF and EGF selectively activate DGKα in cultured VSMCs. α-Thrombin activated a different DGK isoform. The present study thus contributes to the growing body of evidence that DGKα [7, 49, 52] and other DGKs [48, 49, 53] are individually regulated by extracellular signals. DGKs phosphorylate only DAG arising from stimulated PI turnover [11] [12] [13] . As conversion of DAG into other lipids, such as phosphatidylcholine or triacylglycerol, does not proceed through a PA intermediate, DGKs channel PI-derived DAG back into PI resynthesis. DGK inhibition may thus contribute to alterations in inositol-lipid metabolism associated with diabetes [25] . However, further studies will be required to demonstrate this.
Diabetes is associated with development of micro-and macroangiopathies. Chronic activation of PKC appears to play a critical role in these complications [14] . Work in our laboratory has shown that NEFAs, which are elevated in diabetes, can modulate PKC activation in vascular smooth muscle [23] . We have now shown that fatty acids impair the normal activation of DGKα by PDGF. Reduced DGKα activity may thus contribute to chronic PKC activation in the diabetic vasculature. Consistent with this inhibition of a retinal DGK with R59949 elicits microvascular changes similar to those in early diabetes [54] . Moreover, activation of a vascular DGK by high concentrations of α-tocopherol may contribute to prevention of diabetes-induced PKC activation by this agent [55] [56] [57] . Such results indicate that DGK inhibition mimics diabetes-induced vascular changes, but do not prove that this mechanism is operating in diabetes. In this regard, Nobe et al. have shown that the total DGK activities of aortas and kidneys from streptozotocin-diabetic rats are markedly reduced [26] . A variety of other tissues exhibited no change or modest increases in DGK activity. It should be noted that the changes in DGK activity caused by fatty acids, while modest, are similar in magnitude to the changes in PKC activity that have been reported in diabetes. Our findings thus suggest that impaired DGKα activation in response to local growth factors in the diabetic vasculature may have contributed to the decrease in DGK activity observed by Nobe and co-workers [26] .
How NEFAs inhibit DGKα activation is unknown. Fatty acids and their metabolites exert numerous effects on signalling pathways that may directly or indirectly modulate DGKs [58] . DGKα is the only Ca# + -activated DGK in VSMCs (Table 1) . Unsaturated fatty acids, including oleate, inhibit Ca# + influx through capacitative and voltage-operated channels [59, 60] . Saturated fatty acids do not have these effects. Modulation of Ca# + influx by different NEFAs thus correlates with their inhibition of DGKα activation. Diabetes has been shown to similarly impair Ca# + signalling [18, 19] . Fatty-acid-induced dysregulation of Ca# + signalling and inhibition of DGKα activation may thus contribute to chronic PKC activation in diabetes.
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